Use of toll-like receptor agonist for treating cancer

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 11628201
APP PUB NO 20210169972A1
SERIAL NO

16934556

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention is directed to methods and agents used for treating cancer in Toll-Like Receptor 5-expressing tissues by providing a Toll-Like Receptor agonist such as flagellin. The present invention also relates to protecting the liver from a liver toxicity using a Toll-like receptor agonist.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
CLEVELAND BIOLABS INC73 HIGH STREET SUITE 334 BUFFALO NY 14203

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Burdelya, Lyudmila Lancaster, US 10 136
Gleiberman, Anatoli East Aurora, US 7 64
Gudkov, Andrei East Aurora, US 63 294

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
3.5 Year Payment $1600.00 $800.00 $400.00 Oct 18, 2026
7.5 Year Payment $3600.00 $1800.00 $900.00 Oct 18, 2030
11.5 Year Payment $7400.00 $3700.00 $1850.00 Oct 18, 2034
Fee Large entity fee small entity fee micro entity fee
Surcharge - 3.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00